 | • レポートコード：QYR9ST05249 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、乳がん治療の世界市場について調査・分析し、乳がん治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線療法、生物学的標的療法、乳房手術、ホルモン療法）、用途別（病院、診療所、外来診療室）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の乳がん治療市場動向 ・主要企業別マーケットシェア ・乳がん治療の種類別市場規模2014-2019 （化学療法、放射線療法、生物学的標的療法、乳房手術、ホルモン療法） ・乳がん治療の用途別市場規模2014-2019 （病院、診療所、外来診療室） ・乳がん治療の北米市場：主要企業・種類別/用途別市場規模 ・乳がん治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・乳がん治療の中国市場：主要企業・種類別/用途別市場規模 ・乳がん治療の日本国内市場：主要企業・種類別/用途別市場規模 ・乳がん治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・乳がん治療のインド市場：主要企業・種類別/用途別市場規模 ・乳がん治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （F. Hoffmann-La Roche、Novartis、Merck、Eli Lilly and Company、Johnson & Johnson、Pfizer、AstraZeneca、GlaxoSmithKline、Sun Pharmaceutical Industries、Bayer、Gilead Sciences） ・乳がん治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Breast cancer is the one of the most prevalent cancer and among the leading cause of death in cancer patients. According, to WHO 2013 report 50800 women died of breast cancer in 2011. Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast cancer. Although cancer has spread to other parts of the body, but it is treated as breast cancer only. Usually, metastatic breast cancer occurs months or years after completion of treatment for early or locally advanced stages of breast cancer. Metastatic breast cancer cannot be cured. As it has spread to other organs, so it becomes impossible to get rid of all types of cancer. But the treatment of metastatic breast cancer can extend patient’s life with increasing quality of life. Treatment of metastatic breast cancer is influenced by factors such as symptoms, past treatments, cancer cell characteristics and organs affected.Metastatic breast cancer treatment market is estimated to be driven by the increasing prevalence of breast cancer and its recurrence. Development of new technologies and increasing awareness among people is expected to drive demand for metastatic breast cancer treatment. Unavailability of effective treatment to cure and side effects related to the treatment can restrict the growth of metastatic breast cancer treatment market. High cost associated with the metastatic breast cancer treatment can also hinder the growth of this market.
In 2018, the global Breast Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Breast Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Treatment development in United States, Europe and China.
The key players covered in this study
F. Hoffmann-La Roche
Novartis
Merck
Eli Lilly and Company
Johnson & Johnson
Pfizer
AstraZeneca
GlaxoSmithKline
Sun Pharmaceutical Industries
Bayer
Gilead Sciences
Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Biologic Targeted Therapy
Breast Surgery
Hormone Therapy
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Care Units
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Breast Cancer Treatment status, future forecast, growth opportunity, key market and key players.
To present the Breast Cancer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Breast Cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Breast Cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Biologic Targeted Therapy
1.4.5 Breast Surgery
1.4.6 Hormone Therapy
1.5 Market by Application
1.5.1 Global Breast Cancer Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Care Units
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Breast Cancer Treatment Market Size
2.2 Breast Cancer Treatment Growth Trends by Regions
2.2.1 Breast Cancer Treatment Market Size by Regions (2014-2025)
2.2.2 Breast Cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Breast Cancer Treatment Market Size by Manufacturers
3.1.1 Global Breast Cancer Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Breast Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Breast Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Breast Cancer Treatment Key Players Head office and Area Served
3.3 Key Players Breast Cancer Treatment Product/Solution/Service
3.4 Date of Enter into Breast Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Breast Cancer Treatment Market Size by Type (2014-2019)
4.2 Global Breast Cancer Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Breast Cancer Treatment Market Size (2014-2019)
5.2 Breast Cancer Treatment Key Players in United States
5.3 United States Breast Cancer Treatment Market Size by Type
5.4 United States Breast Cancer Treatment Market Size by Application
6 Europe
6.1 Europe Breast Cancer Treatment Market Size (2014-2019)
6.2 Breast Cancer Treatment Key Players in Europe
6.3 Europe Breast Cancer Treatment Market Size by Type
6.4 Europe Breast Cancer Treatment Market Size by Application
7 China
7.1 China Breast Cancer Treatment Market Size (2014-2019)
7.2 Breast Cancer Treatment Key Players in China
7.3 China Breast Cancer Treatment Market Size by Type
7.4 China Breast Cancer Treatment Market Size by Application
8 Japan
8.1 Japan Breast Cancer Treatment Market Size (2014-2019)
8.2 Breast Cancer Treatment Key Players in Japan
8.3 Japan Breast Cancer Treatment Market Size by Type
8.4 Japan Breast Cancer Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Breast Cancer Treatment Market Size (2014-2019)
9.2 Breast Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Breast Cancer Treatment Market Size by Type
9.4 Southeast Asia Breast Cancer Treatment Market Size by Application
10 India
10.1 India Breast Cancer Treatment Market Size (2014-2019)
10.2 Breast Cancer Treatment Key Players in India
10.3 India Breast Cancer Treatment Market Size by Type
10.4 India Breast Cancer Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Breast Cancer Treatment Market Size (2014-2019)
11.2 Breast Cancer Treatment Key Players in Central & South America
11.3 Central & South America Breast Cancer Treatment Market Size by Type
11.4 Central & South America Breast Cancer Treatment Market Size by Application
12 International Players Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Breast Cancer Treatment Introduction
12.1.4 F. Hoffmann-La Roche Revenue in Breast Cancer Treatment Business (2014-2019)
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Breast Cancer Treatment Introduction
12.2.4 Novartis Revenue in Breast Cancer Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Breast Cancer Treatment Introduction
12.3.4 Merck Revenue in Breast Cancer Treatment Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Eli Lilly and Company
12.4.1 Eli Lilly and Company Company Details
12.4.2 Company Description and Business Overview
12.4.3 Breast Cancer Treatment Introduction
12.4.4 Eli Lilly and Company Revenue in Breast Cancer Treatment Business (2014-2019)
12.4.5 Eli Lilly and Company Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Breast Cancer Treatment Introduction
12.5.4 Johnson & Johnson Revenue in Breast Cancer Treatment Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Breast Cancer Treatment Introduction
12.6.4 Pfizer Revenue in Breast Cancer Treatment Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Breast Cancer Treatment Introduction
12.7.4 AstraZeneca Revenue in Breast Cancer Treatment Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Details
12.8.2 Company Description and Business Overview
12.8.3 Breast Cancer Treatment Introduction
12.8.4 GlaxoSmithKline Revenue in Breast Cancer Treatment Business (2014-2019)
12.8.5 GlaxoSmithKline Recent Development
12.9 Sun Pharmaceutical Industries
12.9.1 Sun Pharmaceutical Industries Company Details
12.9.2 Company Description and Business Overview
12.9.3 Breast Cancer Treatment Introduction
12.9.4 Sun Pharmaceutical Industries Revenue in Breast Cancer Treatment Business (2014-2019)
12.9.5 Sun Pharmaceutical Industries Recent Development
12.10 Bayer
12.10.1 Bayer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Breast Cancer Treatment Introduction
12.10.4 Bayer Revenue in Breast Cancer Treatment Business (2014-2019)
12.10.5 Bayer Recent Development
12.11 Gilead Sciences
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Breast Cancer Treatment Key Market Segments
Table Key Players Breast Cancer Treatment Covered
Table Global Breast Cancer Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Breast Cancer Treatment Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Biologic Targeted Therapy Figures
Table Key Players of Biologic Targeted Therapy
Figure Breast Surgery Figures
Table Key Players of Breast Surgery
Figure Hormone Therapy Figures
Table Key Players of Hormone Therapy
Table Global Breast Cancer Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Care Units Case Studies
Figure Breast Cancer Treatment Report Years Considered
Table Global Breast Cancer Treatment Market Size 2014-2025 (Million US$)
Figure Global Breast Cancer Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Breast Cancer Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Breast Cancer Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Breast Cancer Treatment Market Share by Regions 2014-2019
Figure Global Breast Cancer Treatment Market Share by Regions 2014-2019
Figure Global Breast Cancer Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Breast Cancer Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Breast Cancer Treatment Market Share by Manufacturers (2014-2019)
Figure Global Breast Cancer Treatment Market Share by Manufacturers in 2018
Table Global Breast Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Breast Cancer Treatment Product/Solution/Service
Table Date of Enter into Breast Cancer Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Breast Cancer Treatment Market Size Share by Type (2014-2019)
Figure Global Breast Cancer Treatment Market Size Market Share by Type (2014-2019)
Table Global Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Breast Cancer Treatment Market Size Share by Application (2014-2019)
Figure Global Breast Cancer Treatment Market Size Market Share by Application (2014-2019)
Figure Global Breast Cancer Treatment Revenue Market Share by Application in 2018
Figure United States Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Breast Cancer Treatment Market Share (2018-2019)
Table United States Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Breast Cancer Treatment Market Share by Type (2014-2019)
Table United States Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Breast Cancer Treatment Market Share by Application (2014-2019)
Figure Europe Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Breast Cancer Treatment Market Share (2018-2019)
Table Europe Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Breast Cancer Treatment Market Share by Type (2014-2019)
Table Europe Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Breast Cancer Treatment Market Share by Application (2014-2019)
Figure China Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Breast Cancer Treatment Market Share (2018-2019)
Table China Breast Cancer Treatment Market Size by Type (2014-20189) (Million US$)
Table China Breast Cancer Treatment Market Share by Type (2014-2019)
Table China Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table China Breast Cancer Treatment Market Share by Application (2014-2019)
Figure Japan Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Breast Cancer Treatment Market Share (2018-2019)
Table Japan Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Breast Cancer Treatment Market Share by Type (2014-2019)
Table Japan Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Breast Cancer Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Breast Cancer Treatment Market Share (2018-2019)
Table Southeast Asia Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Breast Cancer Treatment Market Share by Type (2014-2019)
Table Southeast Asia Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Breast Cancer Treatment Market Share by Application (2014-2019)
Figure India Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Breast Cancer Treatment Market Share (2018-2019)
Table India Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table India Breast Cancer Treatment Market Share by Type (2014-2019)
Table India Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table India Breast Cancer Treatment Market Share by Application (2014-2019)
Figure Central & South America Breast Cancer Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Breast Cancer Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Breast Cancer Treatment Market Share (2018-2019)
Table Central & South America Breast Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Breast Cancer Treatment Market Share by Type (2014-2019)
Table Central & South America Breast Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Breast Cancer Treatment Market Share by Application (2014-2019)
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Breast Cancer Treatment Business (2014-2019) (Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table Merck Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Revenue in Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Industries Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table Sun Pharmaceutical Industries Recent Development
Table Bayer Company Details
Table Bayer Revenue in Breast Cancer Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Breast Cancer Treatment Business (2014-2019)
Table Bayer Recent Development
Table Gilead Sciences Company Details
Table Global Breast Cancer Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Breast Cancer Treatment Market Size Share by Regions (2019-2025)
Figure Global Breast Cancer Treatment Market Size Share by Regions in 2025
Figure United States Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Breast Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Breast Cancer Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Breast Cancer Treatment Market Size by Product (2019-2025)
Figure Global Breast Cancer Treatment Market Size by Product in 2025
Table Global Breast Cancer Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Breast Cancer Treatment Market Size by Application (2019-2025)
Figure Global Breast Cancer Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
乳がん治療の世界市場：市場規模・現状・予測 Breast cancer is the one of the most prevalent cancer and among the leading cause of death in cancer patients. According, to WHO 2013 report 50800 women died of breast cancer in 2011. Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread …- HER2陰性乳癌治療の世界市場：市場規模・現状・予測 HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein.In 2018, the global HER2-negative breast cancer Treatment mar…
- 転移癌治療の世界市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 胃腸癌治療の世界市場：市場規模・現状・予測 Gastrointestinal Cancer Devices are various devices used to cure gastrointestinal cancer.Rise in incidences of lymphoma, adenocarcinoma, and gastrointestinal stromal tumors, increase in regulatory approvals for metastatic gastric cancer, low dose radiation technology based devices, and increase in n…
- 乳がん治療法の世界市場：市場規模・現状・予測 Breast cancer is cancer that forms in the cells of the breasts.Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly p…